| Drug addiction J Cami, M Farré New England Journal of Medicine 349 (10), 975-986, 2003 | 1076 | 2003 |
| An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients C Galbán, JC Montejo, A Mesejo, P Marco, S Celaya, ... Critical care medicine 28 (3), 643-648, 2000 | 673 | 2000 |
| Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition R De la Torre, M Farré, PN Roset, N Pizarro, S Abanades, M Segura, ... Therapeutic drug monitoring 26 (2), 137-144, 2004 | 559 | 2004 |
| Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans R De La Torre, M Farre, J Ortuno, M Mas, R Brenneisen, PN Roset, ... British journal of clinical pharmacology 49 (2), 104-109, 2000 | 510 | 2000 |
| Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings A Batalla, S Bhattacharyya, M Yuecel, P Fusar-Poli, JA Crippa, S Nogue, ... PloS one 8 (2), e55821, 2013 | 507 | 2013 |
| Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans M Mas, M Farré, R De la Torre, PN Roset, J Ortuño, J Segura, J Camí Journal of Pharmacology and Experimental Therapeutics 290 (1), 136-145, 1999 | 450 | 1999 |
| Hydroxychloroquine for early treatment of adults with mild coronavirus disease 2019: a randomized, controlled trial O Mitjà, M Corbacho-Monné, M Ubals, C Tebé, J Peñafiel, A Tobias, ... Clinical Infectious Diseases 73 (11), e4073-e4081, 2021 | 384 | 2021 |
| Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis M Torrens, F Fonseca, G Mateu, M Farré Drug and alcohol dependence 78 (1), 1-22, 2005 | 370 | 2005 |
| Mephedrone (4-methylmethcathinone;‘meow meow’): chemical, pharmacological and clinical issues F Schifano, A Albanese, S Fergus, JL Stair, P Deluca, O Corazza, Z Davey, ... Psychopharmacology 214, 593-602, 2011 | 363 | 2011 |
| Hydroxytyrosol disposition in humans E Miro-Casas, MI Covas, M Farre, M Fito, J Ortuno, T Weinbrenner, ... Clinical chemistry 49 (6), 945-952, 2003 | 349 | 2003 |
| Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in D own syndrome mouse models and in humans R De la Torre, S De Sola, M Pons, A Duchon, MM de Lagran, M Farré, ... Molecular nutrition & food research 58 (2), 278-288, 2014 | 348 | 2014 |
| Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans MI Covas, K de la Torre, M Farré-Albaladejo, J Kaikkonen, M Fitó, ... Free Radical Biology and Medicine 40 (4), 608-616, 2006 | 342 | 2006 |
| Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation: a randomized controlled trial J Marrugat, MI Covas, M Fitó, H Schröder, E Miró-Casas, E Gimeno, ... European journal of nutrition 43, 140-147, 2004 | 336 | 2004 |
| Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers R Martin-Santos, J a Crippa, A Batalla, S Bhattacharyya, Z Atakan, ... Current pharmaceutical design 18 (32), 4966-4979, 2012 | 322 | 2012 |
| CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans AR Boobis, AM Lynch, S Murray, R de la Torre, A Solans, M Farré, ... Cancer research 54 (1), 89-94, 1994 | 320 | 1994 |
| Human pharmacology of 3, 4-methylenedioxymeth-amphetamine (" Ecstasy"): psychomotor performance and subjective effects J Camí, M Farré, M Mas, PN Roset, S Poudevida, A Mas, L San, ... Journal of clinical psychopharmacology 20 (4), 455-466, 2000 | 306 | 2000 |
| Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis M Farré, A Mas, M Torrens, V Moreno, J Camı́ Drug and alcohol dependence 65 (3), 283-290, 2002 | 305 | 2002 |
| A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19 O Mitjà, M Corbacho-Monné, M Ubals, A Alemany, C Suñer, C Tebe, ... New England Journal of Medicine 384 (5), 417-427, 2021 | 298 | 2021 |
| Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 … R de la Torre, S de Sola, G Hernandez, M Farré, J Pujol, J Rodriguez, ... The Lancet Neurology 15 (8), 801-810, 2016 | 298 | 2016 |
| Use of letrozole in assisted reproduction: a systematic review and meta-analysis A Requena, J Herrero, J Landeras, E Navarro, JL Neyro, C Salvador, ... Human reproduction update 14 (6), 571-582, 2008 | 290 | 2008 |
